St Jude's neuromodulator fails in migraine trial – US approval unlikely?
This article was originally published in Clinica
Executive Summary
A pivotal US trial of the Genesis neurostimulator, a therapy for chronic migraine developed by St Jude Medical, has missed its primary endpoint.